Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ENTOCompany Name
ENTERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTERO THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTO - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -6.3M | $ 2.92M | 0 |
| 3/31/2025 | $ -5.22M | $ 2.05M | 0 |
| 12/31/2024 | $ -3.88M | $ 1.95M | 0 |
| 9/30/2024 | $ 8.37M | $ 3M | 0.36 |
| 6/30/2024 | $ 9.12M | $ 3.23M | 0.35 |
| 3/31/2024 | $ 16.18M | $ 7.35M | 0.45 |
| 12/31/2023 | $ 3.6M | $ 8.87M | 2.46 |
| 9/30/2023 | $ 3.28M | $ 3.75M | 1.14 |
| 6/30/2023 | $ 881.96K | $ 3.02M | 3.43 |
| 3/31/2023 | $ 2.71M | $ 5.02M | 1.85 |
Key Performance Insights, Last 5 Years
- ENTERO THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 1.51.
- Over the past 5 years, ENTERO THERAPEUTICS INC's average P/B has been 2.29.
- The median P/B for ENTERO THERAPEUTICS INC during this period was 1.75
- ENTERO THERAPEUTICS INC reached its highest P/B over the past 5 years at 7.36.
- The lowest P/B recorded by ENTERO THERAPEUTICS INC in the same timeframe 0.35
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for ENTERO THERAPEUTICS INC is calculated as follows: Market Cap [ $ 21.27M ] / Equity [ $ 14.07M ]
(=) P/B [ 1.51 ] ENTO - Price to Book, Last 5 years
0.35
Minimum
Jun 30, 2024
7.36
Maximum
Jun 30, 2021
2.29
Average
1.75
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |